source
- Webinar Explores AI-Driven Intelligence Engine for Optimizing Antibody, ADC and Peptide CandidatesDrug discovery teams are grappling with an ever‑growing volume of data, and converting that data into actionable insight remains a key hurdle. In a recent BioSpace webinar, Patsnap’s Ben Coverdale…
- Argenx to buy Forte Biosciences for up to $2.2 billion, adding experimental CD122 drug FB102Argenx announced it will acquire Forte Biosciences in a transaction valued at up to $2.2 billion. The purchase price is set at $77 per Forte share, roughly a 41% premium to the previous closing pr…